HOSPITALIZATION COSTS RELATED TO PULMONARY HYPERTENSION (PH) AMONG MEDICARE ADVANTAGE OR COMMERCIALLY INSURED PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) IN THE UNITED STATES

被引：3
|
作者：
Lacey, M. [1 ]
Hunsche, E. [2 ]
Buzinec, P. [1 ]
Drake, W. [3 ]
Nagao, M. [3 ]
Regulier, E. [2 ]
机构：
[1] OptumInsight, Eden Prairie, MN USA
[2] Actel Pharmaceut Ltd, Allschwil, Switzerland
[3] Actel Pharmaceut US Inc, San Francisco, CA USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1184
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A233 / A233
页数：1
相关论文
共 50 条
  • [1] Characterizing Pulmonary Hypertension-Related Hospitalization Costs Among Medicare Advantage or Commercially Insured Patients With Pulmonary Arterial Hypertension: A Retrospective Database Study
    Burke, James P.
    Hunsche, Elke
    Regulier, Etienne
    Nagao, Mitchell
    Buzinec, Paul
    Drake, William, III
    AMERICAN JOURNAL OF MANAGED CARE, 2015, 21 (03): : S47 - S58
  • [2] The direct and indirect health care costs associated with pulmonary arterial hypertension among commercially insured patients in the United States
    Ogbomo, Adesuwa
    Tsang, Yuen
    Mallampati, Rajesh
    Panjabi, Sumeet
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (06): : 608 - 616
  • [3] Loss of Productivity Among Commercially Insured Patients Treated for Pulmonary Arterial Hypertension
    Watzker, A.
    Ferro, C.
    Dieguez, G.
    Park, C.
    Alsumali, A.
    Lautsch, D.
    El-Kersh, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [4] Infection-Related Hospitalization in Pulmonary Arterial Hypertension Patients
    Salman, Z.
    Beshay, S.
    Safdar, Z.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [5] Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States
    Kirson, Noam Y.
    Birnbaum, Howard G.
    Ivanova, Jasmina I.
    Waldman, Tracy
    Joish, Vijay
    Williamson, Todd
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (09) : 1763 - 1768
  • [6] Treatment and survival in patients with pulmonary arterial hypertension (PAH)
    Kremers, Hilal Maradit
    Slusser, Joshua P.
    Scott, Christopher G.
    Primatesta, Paola
    McGoon, Michael D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S25 - S25
  • [7] Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population
    Kirson N.Y.
    Birnbaum H.G.
    Ivanova J.I.
    Waldman T.
    Joish V.
    Williamson T.
    Applied Health Economics and Health Policy, 2011, 9 (5) : 293 - 303
  • [8] Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association Registry
    Fling, Connor
    De Marco, Teresa
    Kime, Noah A.
    Lammi, Matthew R.
    Oppegard, Laura J.
    Ryan, John J.
    Ventetuolo, Corey E.
    White, R. James
    Zamanian, Roham T.
    Leary, Peter J.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2023, 20 (12) : 1718 - 1725
  • [9] Expert Council resolution on pulmonary arterial hypertension (PAH) "Changing the paradigm of treating patients with pulmonary arterial hypertension"
    Chazova, I. E.
    Martynyuk, T. V.
    TERAPEVTICHESKII ARKHIV, 2019, 91 (03) : 114 - 116
  • [10] Excess healthcare resource utilization and costs for commercially insured patients with pulmonary arterial hypertension: A real-world data analysis
    Weiss, Tracey
    Ramey, Dena R.
    Pham, Ngan
    Shaikh, Nazneen Fatima
    Tian, Dajun
    Zhao, Xiaohui
    Near, Aimee M.
    Lautsch, Dominik
    Nathan, Steven D.
    PULMONARY CIRCULATION, 2024, 14 (02)
12345